N/A
Manufactured by Energique, Inc.
26 FDA adverse event reports analyzed
Last updated: 2026-04-15
BRYONIA ALBA ROOT is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Energique, Inc.. The most commonly reported adverse reactions for BRYONIA ALBA ROOT include ABNORMAL SENSATION IN EYE, ASTHMA, BALANCE DISORDER, BLOOD GLUCOSE DECREASED, CHEST DISCOMFORT. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BRYONIA ALBA ROOT.
Out of 5 classified reports for BRYONIA ALBA ROOT:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 26 FDA FAERS reports that mention BRYONIA ALBA ROOT. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ABNORMAL SENSATION IN EYE, ASTHMA, BALANCE DISORDER, BLOOD GLUCOSE DECREASED, CHEST DISCOMFORT, CHROMATURIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Energique, Inc. in connection with BRYONIA ALBA ROOT. Always verify the specific product and NDC with your pharmacist.